Industry Research Reports
Home > Reports > Pharma & Healthcare > Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
NAD+ Intravenous Therapy Market Size(US$)
CAGR 2024-2030
7.5%
Market Size,2030
USD 449
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 291 million
Market Forecast in 2030(Value)
US$ 449 million
CAGR
7.5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
In United States the NAD+ Intravenous Therapy revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States NAD+ Intravenous Therapy market, also covers the segmentation data of other regions in regional level and county level.
NAD+ IV Therapy is a wellness therapy that involves the intravenous administration of nicotinamide adenine dinucleotide (NAD+), a coenzyme crucial for cellular energy production and metabolic processes. This therapy is believed to boost energy levels, enhance cognitive function, and promote overall cellular repair by increasing NAD+ levels, which naturally decline with age.
The global key players of NAD+ Intravenous Therapy include The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, etc. The global five biggest players hold a share of % in 2023.
Global NAD+ Intravenous Therapy Scope and Market Size
NAD+ Intravenous Therapy market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global NAD+ Intravenous Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the NAD+ Intravenous Therapy market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
Market Segmentation
By Company
- The Wellness Lab
- Conciergemdla
- Azivmedics
- Reset IV
- Thedripclub
- Toronto Functional Medicine Centre
- Mobileivmedics
- Rocky Mountain Ivmedics
- Seaside Skin Care
- Premiumhealth
- Effect Doctors
- Nadclinic
- Hydrate IV Bar
- LIVV Natural
- BioReset Medical
- IV Boost UK
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Segment by Application
- Clinic
- Hospital
- Residential
Chapter Outline
Chapter 1: Introduces NAD+ Intravenous Therapy definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of NAD+ Intravenous Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of NAD+ Intravenous Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NAD+ Intravenous Therapy revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 NAD+ Intravenous Therapy Product Introduction
1.2 Global NAD+ Intravenous Therapy Outlook, 2019 VS 2023 VS 2030
1.2.1 Global NAD+ Intravenous Therapy Market Size for the Year 2019-2030
1.2.2 United States NAD+ Intravenous Therapy Market Size for the Year 2019-2030
1.3 NAD+ Intravenous Therapy Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States NAD+ Intravenous Therapy in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of NAD+ Intravenous Therapy Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 NAD+ Intravenous Therapy Market Dynamics
1.4.1 NAD+ Intravenous Therapy Industry Trends
1.4.2 NAD+ Intravenous Therapy Market Drivers
1.4.3 NAD+ Intravenous Therapy Market Challenges
1.4.4 NAD+ Intravenous Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 NAD+ Intravenous Therapy by Type
2.1 NAD+ Intravenous Therapy Market by Type
2.1.1 NAD+ Mixed Vitamin Injections
2.1.2 Pure NAD+ Injection
2.2 Global NAD+ Intravenous Therapy Market Size by Type (2019, 2023 & 2030)
2.3 Global NAD+ Intravenous Therapy Market Size by Type (2019-2030)
2.4 United States NAD+ Intravenous Therapy Market Size by Type (2019, 2023 & 2030)
2.5 United States NAD+ Intravenous Therapy Market Size by Type (2019-2030)
3 NAD+ Intravenous Therapy by Application
3.1 NAD+ Intravenous Therapy Market by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Residential
3.2 Global NAD+ Intravenous Therapy Market Size, by Application (2019, 2023 & 2030)
3.3 Global NAD+ Intravenous Therapy Market Size by Application (2019-2030)
3.4 United States NAD+ Intravenous Therapy Market Size by Application (2019, 2023 & 2030)
3.5 United States NAD+ Intravenous Therapy Market Size by Application (2019-2030)
4 Global NAD+ Intravenous Therapy Competitor Landscape by Company
4.1 Global NAD+ Intravenous Therapy Market Size by Company
4.1.1 Global Key Companies of NAD+ Intravenous Therapy, Ranked by Revenue (2023)
4.1.2 Global NAD+ Intravenous Therapy Revenue by Player (2019-2024)
4.2 Global NAD+ Intravenous Therapy Concentration Ratio (CR)
4.2.1 NAD+ Intravenous Therapy Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of NAD+ Intravenous Therapy in 2023
4.2.3 Global NAD+ Intravenous Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of NAD+ Intravenous Therapy Head office and Area Served
4.4 Global Key Players of NAD+ Intravenous Therapy, Product and Application
4.5 Global Key Players of NAD+ Intravenous Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States NAD+ Intravenous Therapy Market Size by Company
4.7.1 Key Players of NAD+ Intravenous Therapy in United States, Ranked by Revenue (2023)
4.7.2 United States NAD+ Intravenous Therapy Revenue by Players (2022, 2023 & 2024)
5 Global NAD+ Intravenous Therapy Market Size by Region
5.1 Global NAD+ Intravenous Therapy Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global NAD+ Intravenous Therapy Market Size by Region (2019-2030)
5.2.1 Global NAD+ Intravenous Therapy Market Size by Region: 2019-2024
5.2.2 Global NAD+ Intravenous Therapy Market Size by Region: 2025-2030
6 Americas
6.1 Americas NAD+ Intravenous Therapy Market Size YoY Growth 2019-2030
6.2 Americas NAD+ Intravenous Therapy Market Size by Type
6.2.1 Americas NAD+ Intravenous Therapy Market Size by Type (2019-2024)
6.2.2 Americas NAD+ Intravenous Therapy Market Size by Type (2025-2030)
6.2.3 Americas NAD+ Intravenous Therapy Market Share by Type (2019-2030)
6.3 Americas NAD+ Intravenous Therapy Market Size by Application
6.3.1 Americas NAD+ Intravenous Therapy Market Size by Application (2019-2024)
6.3.2 Americas NAD+ Intravenous Therapy Market Size by Application (2025-2030)
6.3.3 Americas NAD+ Intravenous Therapy Market Share by Application (2019-2030)
6.4 Americas NAD+ Intravenous Therapy Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA NAD+ Intravenous Therapy Market Size YoY Growth 2019-2030
7.2 EMEA NAD+ Intravenous Therapy Market Size by Type
7.2.1 EMEA NAD+ Intravenous Therapy Market Size by Type (2019-2024)
7.2.2 EMEA NAD+ Intravenous Therapy Market Size by Type (2025-2030)
7.2.3 EMEA NAD+ Intravenous Therapy Market Share by Type (2019-2030)
7.3 EMEA NAD+ Intravenous Therapy Market Size by Application
7.3.1 EMEA NAD+ Intravenous Therapy Market Size by Application (2019-2024)
7.3.2 EMEA NAD+ Intravenous Therapy Market Size by Application (2025-2030)
7.3.3 EMEA NAD+ Intravenous Therapy Market Share by Application (2019-2030)
7.4 EMEA NAD+ Intravenous Therapy Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China NAD+ Intravenous Therapy Market Size by Type
8.1.1 China NAD+ Intravenous Therapy Market Size by Type (2019-2024)
8.1.2 China NAD+ Intravenous Therapy Market Size by Type (2025-2030)
8.1.3 China NAD+ Intravenous Therapy Market Share by Type (2019-2030)
8.2 China NAD+ Intravenous Therapy Market Size by Application
8.2.1 China NAD+ Intravenous Therapy Market Size by Application (2019-2024)
8.2.2 China NAD+ Intravenous Therapy Market Size by Application (2025-2030)
8.2.3 China NAD+ Intravenous Therapy Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC NAD+ Intravenous Therapy Market Size YoY Growth 2019-2030
9.2 APAC NAD+ Intravenous Therapy Market Size by Type
9.2.1 APAC NAD+ Intravenous Therapy Market Size by Type (2019-2024)
9.2.2 APAC NAD+ Intravenous Therapy Market Size by Type (2025-2030)
9.2.3 APAC NAD+ Intravenous Therapy Market Share by Type (2019-2030)
9.3 APAC NAD+ Intravenous Therapy Market Size by Application
9.3.1 APAC NAD+ Intravenous Therapy Market Size by Application (2019-2024)
9.3.2 APAC NAD+ Intravenous Therapy Market Size by Application (2025-2030)
9.3.3 APAC NAD+ Intravenous Therapy Market Share by Application (2019-2030)
9.4 APAC NAD+ Intravenous Therapy Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 The Wellness Lab
10.1.1 The Wellness Lab Company Details
10.1.2 The Wellness Lab Business Overview
10.1.3 The Wellness Lab NAD+ Intravenous Therapy Introduction
10.1.4 The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.1.5 The Wellness Lab Recent Development
10.2 Conciergemdla
10.2.1 Conciergemdla Company Details
10.2.2 Conciergemdla Business Overview
10.2.3 Conciergemdla NAD+ Intravenous Therapy Introduction
10.2.4 Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.2.5 Conciergemdla Recent Development
10.3 Azivmedics
10.3.1 Azivmedics Company Details
10.3.2 Azivmedics Business Overview
10.3.3 Azivmedics NAD+ Intravenous Therapy Introduction
10.3.4 Azivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.3.5 Azivmedics Recent Development
10.4 Reset IV
10.4.1 Reset IV Company Details
10.4.2 Reset IV Business Overview
10.4.3 Reset IV NAD+ Intravenous Therapy Introduction
10.4.4 Reset IV Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.4.5 Reset IV Recent Development
10.5 Thedripclub
10.5.1 Thedripclub Company Details
10.5.2 Thedripclub Business Overview
10.5.3 Thedripclub NAD+ Intravenous Therapy Introduction
10.5.4 Thedripclub Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.5.5 Thedripclub Recent Development
10.6 Toronto Functional Medicine Centre
10.6.1 Toronto Functional Medicine Centre Company Details
10.6.2 Toronto Functional Medicine Centre Business Overview
10.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Introduction
10.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.6.5 Toronto Functional Medicine Centre Recent Development
10.7 Mobileivmedics
10.7.1 Mobileivmedics Company Details
10.7.2 Mobileivmedics Business Overview
10.7.3 Mobileivmedics NAD+ Intravenous Therapy Introduction
10.7.4 Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.7.5 Mobileivmedics Recent Development
10.8 Rocky Mountain Ivmedics
10.8.1 Rocky Mountain Ivmedics Company Details
10.8.2 Rocky Mountain Ivmedics Business Overview
10.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Introduction
10.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.8.5 Rocky Mountain Ivmedics Recent Development
10.9 Seaside Skin Care
10.9.1 Seaside Skin Care Company Details
10.9.2 Seaside Skin Care Business Overview
10.9.3 Seaside Skin Care NAD+ Intravenous Therapy Introduction
10.9.4 Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.9.5 Seaside Skin Care Recent Development
10.10 Premiumhealth
10.10.1 Premiumhealth Company Details
10.10.2 Premiumhealth Business Overview
10.10.3 Premiumhealth NAD+ Intravenous Therapy Introduction
10.10.4 Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.10.5 Premiumhealth Recent Development
10.11 Effect Doctors
10.11.1 Effect Doctors Company Details
10.11.2 Effect Doctors Business Overview
10.11.3 Effect Doctors NAD+ Intravenous Therapy Introduction
10.11.4 Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.11.5 Effect Doctors Recent Development
10.12 Nadclinic
10.12.1 Nadclinic Company Details
10.12.2 Nadclinic Business Overview
10.12.3 Nadclinic NAD+ Intravenous Therapy Introduction
10.12.4 Nadclinic Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.12.5 Nadclinic Recent Development
10.13 Hydrate IV Bar
10.13.1 Hydrate IV Bar Company Details
10.13.2 Hydrate IV Bar Business Overview
10.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Introduction
10.13.4 Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.13.5 Hydrate IV Bar Recent Development
10.14 LIVV Natural
10.14.1 LIVV Natural Company Details
10.14.2 LIVV Natural Business Overview
10.14.3 LIVV Natural NAD+ Intravenous Therapy Introduction
10.14.4 LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.14.5 LIVV Natural Recent Development
10.15 BioReset Medical
10.15.1 BioReset Medical Company Details
10.15.2 BioReset Medical Business Overview
10.15.3 BioReset Medical NAD+ Intravenous Therapy Introduction
10.15.4 BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.15.5 BioReset Medical Recent Development
10.16 IV Boost UK
10.16.1 IV Boost UK Company Details
10.16.2 IV Boost UK Business Overview
10.16.3 IV Boost UK NAD+ Intravenous Therapy Introduction
10.16.4 IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2019-2024)
10.16.5 IV Boost UK Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. NAD+ Intravenous Therapy Market Size, United States VS Global, CAGR (2019 VS 2023 VS 2030)
Table 2. NAD+ Intravenous Therapy Market Trends
Table 3. NAD+ Intravenous Therapy Market Drivers
Table 4. NAD+ Intravenous Therapy Market Challenges
Table 5. NAD+ Intravenous Therapy Market Restraints
Table 6. Global NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. United States NAD+ Intravenous Therapy Market Size by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. United States NAD+ Intravenous Therapy Market Size by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Key Companies of NAD+ Intravenous Therapy, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global NAD+ Intravenous Therapy Revenue by Player, (US$ Million), 2019-2024
Table 12. Global NAD+ Intravenous Therapy Revenue Share by Player, 2019-2024
Table 13. Global NAD+ Intravenous Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global NAD+ Intravenous Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2023)
Table 15. Global Key Players of NAD+ Intravenous Therapy, Headquarters and Area Served
Table 16. Global Key Players of NAD+ Intravenous Therapy, Product and Application
Table 17. Global Key Players of NAD+ Intravenous Therapy, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of NAD+ Intravenous Therapy in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States NAD+ Intravenous Therapy Revenue by Players, (US$ Million), 2022, 2023 & 2024
Table 21. United States NAD+ Intravenous Therapy Revenue Share by Players, 2022, 2023 & 2024
Table 22. Global NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 23. Global NAD+ Intravenous Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 24. Global NAD+ Intravenous Therapy Market Size Forecast by Region (2025-2030) & (US$ Million)
Table 25. Americas NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Americas NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 27. Americas NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Americas NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 29. Americas NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 30. Americas NAD+ Intravenous Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 31. Americas NAD+ Intravenous Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 32. EMEA NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 33. EMEA NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 34. EMEA NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 35. EMEA NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 36. EMEA NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 37. EMEA NAD+ Intravenous Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 38. EMEA NAD+ Intravenous Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 39. China NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 40. China NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 41. China NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 42. China NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 43. APAC NAD+ Intravenous Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 44. APAC NAD+ Intravenous Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 45. APAC NAD+ Intravenous Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 46. APAC NAD+ Intravenous Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 47. APAC NAD+ Intravenous Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 48. APAC NAD+ Intravenous Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 49. APAC NAD+ Intravenous Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 50. The Wellness Lab Company Details
Table 51. The Wellness Lab Business Overview
Table 52. The Wellness Lab NAD+ Intravenous Therapy Product
Table 53. The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 54. The Wellness Lab Recent Development
Table 55. Conciergemdla Company Details
Table 56. Conciergemdla Business Overview
Table 57. Conciergemdla NAD+ Intravenous Therapy Product
Table 58. Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 59. Conciergemdla Recent Development
Table 60. Azivmedics Company Details
Table 61. Azivmedics Business Overview
Table 62. Azivmedics NAD+ Intravenous Therapy Product
Table 63. Azivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 64. Azivmedics Recent Development
Table 65. Reset IV Company Details
Table 66. Reset IV Business Overview
Table 67. Reset IV NAD+ Intravenous Therapy Product
Table 68. Reset IV Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 69. Reset IV Recent Development
Table 70. Thedripclub Company Details
Table 71. Thedripclub Business Overview
Table 72. Thedripclub NAD+ Intravenous Therapy Product
Table 73. Thedripclub Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 74. Thedripclub Recent Development
Table 75. Toronto Functional Medicine Centre Company Details
Table 76. Toronto Functional Medicine Centre Business Overview
Table 77. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product
Table 78. Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 79. Toronto Functional Medicine Centre Recent Development
Table 80. Mobileivmedics Company Details
Table 81. Mobileivmedics Business Overview
Table 82. Mobileivmedics NAD+ Intravenous Therapy Product
Table 83. Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 84. Mobileivmedics Recent Development
Table 85. Rocky Mountain Ivmedics Company Details
Table 86. Rocky Mountain Ivmedics Business Overview
Table 87. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product
Table 88. Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 89. Rocky Mountain Ivmedics Recent Development
Table 90. Seaside Skin Care Company Details
Table 91. Seaside Skin Care Business Overview
Table 92. Seaside Skin Care NAD+ Intravenous Therapy Product
Table 93. Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 94. Seaside Skin Care Recent Development
Table 95. Premiumhealth Company Details
Table 96. Premiumhealth Business Overview
Table 97. Premiumhealth NAD+ Intravenous Therapy Product
Table 98. Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 99. Premiumhealth Recent Development
Table 100. Effect Doctors Company Details
Table 101. Effect Doctors Business Overview
Table 102. Effect Doctors NAD+ Intravenous Therapy Product
Table 103. Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 104. Effect Doctors Recent Development
Table 105. Nadclinic Company Details
Table 106. Nadclinic Business Overview
Table 107. Nadclinic NAD+ Intravenous Therapy Product
Table 108. Nadclinic Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 109. Nadclinic Recent Development
Table 110. Hydrate IV Bar Company Details
Table 111. Hydrate IV Bar Business Overview
Table 112. Hydrate IV Bar NAD+ Intravenous Therapy Product
Table 113. Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 114. Hydrate IV Bar Recent Development
Table 115. LIVV Natural Company Details
Table 116. LIVV Natural Business Overview
Table 117. LIVV Natural NAD+ Intravenous Therapy Product
Table 118. LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 119. LIVV Natural Recent Development
Table 120. BioReset Medical Company Details
Table 121. BioReset Medical Business Overview
Table 122. BioReset Medical NAD+ Intravenous Therapy Product
Table 123. BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 124. BioReset Medical Recent Development
Table 125. IV Boost UK Company Details
Table 126. IV Boost UK Business Overview
Table 127. IV Boost UK NAD+ Intravenous Therapy Product
Table 128. IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2019-2024) & (US$ Million)
Table 129. IV Boost UK Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. NAD+ Intravenous Therapy Product Picture
Figure 2. Global NAD+ Intravenous Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global NAD+ Intravenous Therapy Market Size 2019-2030 (US$ Million)
Figure 4. United States NAD+ Intravenous Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 5. United States NAD+ Intravenous Therapy Market Size 2019-2030 (US$ Million)
Figure 6. United States NAD+ Intravenous Therapy Market Share in Global 2019-2030
Figure 7. NAD+ Intravenous Therapy Report Years Considered
Figure 8. Product Picture of NAD+ Mixed Vitamin Injections
Figure 9. Product Picture of Pure NAD+ Injection
Figure 10. Global NAD+ Intravenous Therapy Market Share by Type in 2023 & 2030
Figure 11. Global NAD+ Intravenous Therapy Market Size by Type (2019-2030) & (US$ Million)
Figure 12. Global NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 13. United States NAD+ Intravenous Therapy Market Share by Type in 2023 & 2030
Figure 14. United States NAD+ Intravenous Therapy Market Size by Type (2019-2030) & (US$ Million)
Figure 15. United States NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 16. Product Picture of Clinic
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Residential
Figure 19. Global NAD+ Intravenous Therapy Market Share by Application in 2023 & 2030
Figure 20. Global NAD+ Intravenous Therapy Market Size by Application (2019-2030) & (US$ Million)
Figure 21. Global NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 22. United States NAD+ Intravenous Therapy Market Share by Application in 2023 & 2030
Figure 23. United States NAD+ Intravenous Therapy Market Size by Application (2019-2030) & (US$ Million)
Figure 24. United States NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 25. The Top 5 and 10 Largest Companies of NAD+ Intravenous Therapy in the World: Market Share by NAD+ Intravenous Therapy Revenue in 2023
Figure 26. Global NAD+ Intravenous Therapy Market Size Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global NAD+ Intravenous Therapy Market Share by Region (2019-2030)
Figure 28. Americas NAD+ Intravenous Therapy Market Size Growth Rate 2019-2030 (US$ Million)
Figure 29. Americas NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 30. Americas NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 31. United States NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 33. Mexico NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 34. Brazil NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 35. EMEA NAD+ Intravenous Therapy Market Size Growth Rate 2019-2030 (US$ Million)
Figure 36. EMEA NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 37. EMEA NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 38. Europe NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 39. Middle East NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 40. Africa NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 41. China NAD+ Intravenous Therapy Market Size Growth Rate 2019-2030 (US$ Million)
Figure 42. China NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 43. China NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 44. APAC NAD+ Intravenous Therapy Market Size Growth Rate 2019-2030 (US$ Million)
Figure 45. APAC NAD+ Intravenous Therapy Market Share by Type (2019-2030)
Figure 46. APAC NAD+ Intravenous Therapy Market Share by Application (2019-2030)
Figure 47. Japan NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 48. South Korea NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 49. China Taiwan NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 50. ASEAN NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 51. India NAD+ Intravenous Therapy Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 52. The Wellness Lab Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 53. Conciergemdla Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 54. Azivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 55. Reset IV Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 56. Thedripclub Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 57. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 58. Mobileivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 59. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 60. Seaside Skin Care Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 61. Premiumhealth Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 62. Effect Doctors Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 63. Nadclinic Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 64. Hydrate IV Bar Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 65. LIVV Natural Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 66. BioReset Medical Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 67. IV Boost UK Revenue Growth Rate in NAD+ Intravenous Therapy Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Related Reports
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published Date: 2024-11-11
Pages: 154
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published Date: 2024-11-11
Pages: 100
USD 2900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 125
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 105
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 117
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 105
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 133
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published: 2024-11-11
Pages: 154
USD 4900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published: 2024-11-11
Pages: 100
USD 2900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-03-13
Pages: 97
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 125
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 105
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 117
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 105
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 133
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research